Appendix E1-IRB Approval-RTI_Apr2[1]

Appendix E1-IRB Approval-RTI_Apr2[1].pdf

Study to Improve Thyroid Doses from Fallout Exposure in Kazakhstan

Appendix E1-IRB Approval-RTI_Apr2[1]

OMB: 0925-0582

Document [pdf]
Download: pdf | pdf
Appendix E1 - IRB Approval - RTI
IRB ID Number: 11746
Office of Research Protection and Ethics

Institutional Review Board Notice of Approval
Federalwide Assurance No. 3331
Title of Study: Study to Improve Thyroid Doses from Fallout Exposure in Kazakhstan
RTI Project Number: 0208859.000.160
RTI Proposal Number (if no Project Number)
Project Leader: Heinrich, John
Project Team Member Contact (if different from Project Leader): Noelle Richa
Source of Funding for this Study: National Cancer Institute
Date Submitted to IRB: March 2, 2007
Level of Review (check one):
Full , IRB Meeting Date:
Expedited , category: 7: Behavioral - surveys, focus groups, etc.
Type of Review (check one):
Preliminary review (Do not involve human subjects or data until pretest or full study is approved.)
Pretest/Pilot Test:
Full Implementation
Amendment, describe: revised screeners, focus group guides questionnaire and new payment
receipt for focus group interviews
Add study site(s):
Renewal
Study Closure
IRB Approval of Special Conditions (check all that apply):
Waiver of Signed Informed Consent/Parental Permission
Participation of Pregnant Women (Worksheet B submitted by project team)
Participation of Prisoners (Worksheet C submitted by project team
Participation of Prisoners in DHHS-funded studies (OHRP acknowledgement received)
Participation of Minors (Worksheet D submitted by project team)
IRB Agreement of Nonsignificant Risk Device Study Determination
Please note the following requirements:
• If unexpected problems or adverse events occur, the project team must notify the IRB.
• If there are changes in study procedures or protocol or any data collection materials (brochures, letters,
questionnaires, etc.) the project team must notify the IRB before they are implemented.
• The project team is required to apply for continuing review as long as the study is active, which includes
participation of human subjects or possession of human data or specimens.

Expiration Date of IRB Approval: February 15, 2008
(No human subjects research can occur after this date without continuing review and approval.)
March 5, 2007
Signature - IRB Member or Chair
Wendy A. Visscher, PhD
Name - IRB Member or Chair (print or type)
Copy sent to project leader on: March 5, 2007
Entered into MIS

Office of Research Protection, Institutional Review Board
3040 Cornwallis Road, Research Triangle Park, NC 27709-2194, USA
Telephone: 919-316-3358 Fax: 919-316-3897 [email protected]

Date of IRB Approval


File Typeapplication/pdf
File TitleApproval Notice.11746.Amend.3-2-07.doc
File Modified2007-04-02
File Created0000-00-00

© 2024 OMB.report | Privacy Policy